More Sway for FDA Is Object of New Bill

More Sway for FDA Is Object of New Bill

A bipartisan committee of lawmakers from the Senate and the House reached a compromise on Wednesday on legislation that would give the Food and Drug Administration greater control over compounding pharmacies. But analysts said it was still unclear 

5
Like
Save

Comments

Write a comment

*